INmune Bio Inc. Common stock (INMB) Stock Price, Quote & AI Analysis
Live INMB stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for INmune Bio Inc. Common stock.
TradeVae provides AI-driven analysis and real-time market intelligence for INmune Bio Inc. Common stock (INMB), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
INmune Bio Inc. Common stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
INmune Bio Inc. Common stock Overview
Company information
Company Overview
INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
INmune Bio Inc. Common stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...